HomeInsightsPE

Concord Drugs Ltd PE Ratio

Concord Drugs Ltd PE Ratio

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

1.0 K

stocks traded

Last Updated time: 14 Oct 10:27 AM

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

PE

0

Last updated: 14 Oct 10:27 AM

Key Highlights

  • The P/E Ratio of Concord Drugs Ltd is 0 as of 14 Oct 10:27 AM.
  • The P/E Ratio of Concord Drugs Ltd changed from 15.9 on March 2022 to 74.8 on March 2024 . This represents a CAGR of 67.56% over 3 years. .
  • The Latest Trading Price of Concord Drugs Ltd is ₹ 36.58 as of 14 Oct 10:20.
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.2. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 158.1. The PE Ratio of Textiles industry is 37.6. In 2024.

Historical P/E Ratio of Concord Drugs Ltd

No data available

Company Fundamentals for Concord Drugs Ltd

No data available

Image

Concord Drugs Ltd

NSE: CONCORDDRUGS

PRICE

36.58

-0.60 (-1.61%)

stock direction

Last updated: 14 Oct 10:20

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Concord Drugs Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
11 Oct 202437.18
10 Oct 202437
09 Oct 202437.33
08 Oct 202436.57
07 Oct 202436.51
04 Oct 202436.93
03 Oct 202437.18
01 Oct 202437.58
30 Sep 202437.24
27 Sep 202437.27

BlinkX Score for Concord Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Drugs Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Concord Drugs Ltd037
Sun Pharmaceuticals Industries Ltd434,56,342
Divis Laboratories Ltd971,63,028
Cipla Ltd291,28,827
Torrent Pharmaceuticals Ltd701,18,373
Mankind Pharma Ltd571,11,956

Key Valuation Metric of Concord Drugs Ltd

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Concord Drugs Ltd

No data available

* All values are in crore

Historical Revenue of Concord Drugs Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Drugs Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Drugs Ltd

No data available

* All values are in crore

Historical Dividend Payout of Concord Drugs Ltd

No data available

* All values are in %

About Concord Drugs Ltd

  • Concord Drugs Limited, established in 1995, is amongst the respected pharmaceutical companies in India for manufacturing of Finished Pharmaceutical Formulations like Injectables (Small Volume parenterals, Dry Syrup powder) ,Tissue Bio-Adhesive, tablets, capsules and ophthalmic preparations and Ready-to-fill Pellets. The principal activity of the Company is to manufacture licensed drugs based on the formulations approved.
  • The Company has two manufacturing facilities license issued by The Government of Andhra Pradesh, Drugs Control Administration, and Hyderabad.
  • State of the art technology having dedicated manufacturing facilities for Liquid Injections, Dry powder Injections and Ready-to-fill Pellets ensures the highest level of process integrity and product quality. The Company started with Finished Pharmaceutical Formulations and then diversified into Ready-to-fill Pellets, to provide customers with end-to-end solution to their various pharmaceutical product needs to commercial contract drug manufacturing.

Concord Drugs Ltd News Hub

News

Concord Drugs to conduct AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 202417:57

News

Concord Drugs schedules AGM

Concord Drugs announced that the Annual General Meeting (AGM) of the company will be held ...

Read more

19 Sep 202410:06

News

Concord Drugs fixes board meeting date

Concord Drugs will hold a meeting of the Board of Directors of the Company on 6 September ...

Read more

03 Sep 202411:10

News

Concord Drugs to table results

Concord Drugs will hold a meeting of the Board of Directors of the Company on 9 August 202...

Read more

06 Aug 202416:20

News

Concord Drugs postpones board meeting

Concord Drugs has postponed the meeting of the Board of Directors which was scheduled to b...

Read more

25 May 202411:26

News

Concord Drugs declare Quarterly Result

Concord Drugs will hold a meeting of the Board of Directors of the Company on 25 May 2024 ...

Read more

16 May 202412:41

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for PE of Concord Drugs Ltd

What is the current PE Ratio of Concord Drugs Ltd?

The Current PE Ratio of Concord Drugs Ltd is 0.0 as on 14 Oct 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 14 Oct 2024.

What was the PE Ratio of Concord Drugs Ltd last year?

The PE Ratio of Concord Drugs Ltd was 25.9 last year, now the PE ratio is 0.0, showing a year-on-year growth of -100.0%.

What does the PE Ratio of Concord Drugs Ltd indicate about its stock?

The PE Ratio of Concord Drugs Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Concord Drugs Ltd.

What is the PE Ratio Growth of Concord Drugs Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Concord Drugs Ltd grew by -100.0% whereas, the EPS ratio grew by -108.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*